|By PR Newswire||
|April 28, 2014 07:26 AM EDT||
DUBLIN, Apr. 28, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/85rshn/global) has announced the addition of the "Global Therapeutic Vaccines Market 2014-2018" report to their offering.
A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, which are administered to an individual with a disease in order to induce a defense mechanism. There are two approved cancer therapeutic vaccines on the market; Provenge and Oncophage. Additionally, a large number of therapeutic vaccines are under clinical development and are expected to be approved for use during the forecast period.
The analysts forecast the Global Therapeutic Vaccines market to grow at a CAGR of 62.81 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Therapeutic Vaccine market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapeutic vaccines available in the market.
The report, the Global Therapeutic Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Therapeutic Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
06. Market Landscape
07. Geographical Segmentation
08. Key Leading Countries
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Pipeline Analysis
17. Vendor Landscape
18. Key Vendor Analysis
- AFFiRiS AG.
- Agenus Inc.
- Argos Therapeutics Inc
- Bavarian Nordic A/S.
- CEL-SCI Corp.
- Celldex Therapeutics Inc.
- Cytos Biotechnology AG
- Dendreon Corp.
- GlaxoSmithKline plc
- GlobeImmune Inc.
- NewLink GeneticsCorp.
- NovaRx Corp.
- Novartis International AG
- Oncothyreon Inc.
- TVAX Biomedical Inc.
- TapImmune Inc
- Vaccinogen Inc.
- Vical Inc.
For more information visit http://www.researchandmarkets.com/research/85rshn/global
Media Contact: Laura Wood, +353-1-481-1716, [email protected]
Aug. 26, 2016 07:15 PM EDT Reads: 364
Aug. 26, 2016 07:00 PM EDT Reads: 651
Aug. 26, 2016 07:00 PM EDT Reads: 623
Aug. 26, 2016 06:00 PM EDT Reads: 1,912
Aug. 26, 2016 05:00 PM EDT Reads: 661
Aug. 26, 2016 04:45 PM EDT Reads: 1,522
Aug. 26, 2016 04:30 PM EDT Reads: 2,294
Aug. 26, 2016 04:00 PM EDT Reads: 3,927
Aug. 26, 2016 03:45 PM EDT Reads: 546
Aug. 26, 2016 03:15 PM EDT Reads: 402
Aug. 26, 2016 01:30 PM EDT Reads: 3,409
Aug. 26, 2016 01:00 PM EDT Reads: 1,971
Aug. 26, 2016 12:30 PM EDT Reads: 630
Aug. 26, 2016 11:45 AM EDT Reads: 667
Aug. 26, 2016 11:45 AM EDT Reads: 582